Kaynaklar
- Ecder T, Chapman AB, Brosnahan GM, Edelstein CL, Johnson AM, Schrier RW: Effect of antihypertensive therapy on renal function and urinary albumin excretion in hypertensive patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 35: 427-432, 2000.
- Ecder T, Edelstein CL, Chapman AB, Johnson AM, Tison L, Gill EA, Brosnahan GM, Schrier RW: Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease. Nephrology Dialysis Transplantation 14: 1113-1116, 1999.
- Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Chapman AB, Gabow PA, Schrier RW: Diuretics versus angiotensin-converting enzyme inhibitors in autosomal dominant polycystic kidney disease. American Journal of Nephrology 21: 98-103, 2001.
- Ecder T, Edelstein CL, Fick-Brosnahan GM, Johnson AM, Duley IT, Gabow PA, Schrier RW: Progress in blood pressure control in autosomal dominant polycystic kidney disease. American Journal of Kidney Diseases 36: 266-271, 2000.
- Ecder T, McFann KK, Raynolds MV, Schrier RW: No effect of angiotensin-converting enzyme gene polymorphism on disease progression and left ventricular hypertrophy in autosomal dominant polycystic kidney disease. American Journal of Nephrology 23: 466-470, 2003.
- Ecder T, Melnikov VY, Stanley M, Korular D, Lucia MS, Schrier RW, Edelstein CL: Caspases, Bcl-2 proteins and apoptosis in autosomal-dominant polycystic kidney disease. Kidney Int 61: 1220-1230, 2002.
- Ecder T, Schrier RW: Hypertension in autosomal-dominant polycystic kidney disease: Early occurrence and unique aspects. Journal of the American Society of Nephrology 12: 194-200, 2001.
- Fick GM, Gabow PA: Hereditary and acquired cystic disease of the kidney. Kidney Int 46: 951-964, 1994.
- Fick-Brosnahan GM, Ecder T, Schrier RW: Chapter 18: Polycystic Kidney Disease. Diseases of the Kidney and Urinary Tract. Seventh Edition. Edited by Robert W. Schrier. Lippincott Williams and Wilkins, pp: 547-588, 2001.
- Gabow PA: Autosomal dominant polycystic kidney disease. N Engl J Med 329: 332-342, 1993.
- Grantham JJ: The etiology, pathogenesis, and treatment of autosomal dominant polycystic kidney disease. Am J Kidney Dis 28: 788-803, 1996.
- Murcia NS, Woychik RP, Avner ED: The molecular biology of polycystic kidney disease. Pediatr Nephrol 12: 721-726, 1998.
- Murcia NS, Sweeney WE, Avner ED: New insights into the molecular pathophysiology of polycystic kidney disease. Kidney Int 55: 1187-1197, 1999.
- Pei Y: Molecular genetics of autosomal dominant polycystic kidney disease. Clin Invest Med 26: 252-258, 2003.
- Schrier R, McFann K, Johnson A, Chapman A, Edelstein C, Brosnahan G, Ecder T, Tison L: Cardiac and renal effects of standard versus rigorous blood pressure control in autosomal dominant polycystic kidney disease: Results of a seven-year prospective randomized study. J Am Soc Nephrol 13: 1733-1739, 2002.
- Watnick T, Germino GG: Molecular basis of autosomal dominant polycystic kidney disease. Semin Nephrol 19: 327-343, 1999.
.gif){kind=small}